{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:24Z","timestamp":1791037044653,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.ygyno.2005.01.039","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T13:29:45Z","timestamp":1111670985000},"page":"457-467","source":"Crossref","is-referenced-by-count":78,"title":["Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations"],"prefix":"10.1016","volume":"97","author":[{"given":"Murray Joseph","family":"Casey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Synder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhanda","family":"Bewtra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry T.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.01.039_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001703-200102000-00004","article-title":"Current status of prophylactic surgery for hereditary breast and gynecologic cancers","volume":"13","author":"Lynch","year":"2001","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families","volume":"ii","author":"Tobacman","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2005.01.039_bib3","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","article-title":"Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer: a report of the Gilda Radner Familial Ovarian Cancer Registry","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib4","first-page":"33","article-title":"Prophylactic oophorectomy in inherited breast\/ovarian cancer families","volume":"17","author":"Struewing","year":"1995","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2005.01.039_bib5","first-page":"42","article-title":"A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families","volume":"58","author":"Serova","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.01.039_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00000478-198104000-00004","article-title":"Papillary peritoneal tumors in women","volume":"5","author":"Foyle","year":"1981","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004347-198501000-00002","article-title":"Multiple focal extraovarian serous carcinoma","volume":"4","author":"August","year":"1985","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0046-8177(89)90006-3","article-title":"Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases","volume":"20","author":"Raju","year":"1989","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5","article-title":"Extraovarian peritoneal serous papillary carcinoma: a clinicopathologic study of 31 cases","volume":"64","author":"Dalrymple","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F","article-title":"Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy","volume":"66","author":"Ransom","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.1993.1267","article-title":"Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma","volume":"51","author":"Killackey","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/gyno.1996.0060","article-title":"Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III\u2013IV ovarian papillary serous carcinoma","volume":"60","author":"Ben-Baruch","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1587::AID-CNCR22>3.0.CO;2-T","article-title":"A case-matched comparison of extraovarian versus primary ovarian adenocarcinoma","volume":"79","author":"Kowalski","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0301-2115(00)00521-2","article-title":"Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier","volume":"97","author":"Piura","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasm in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up","volume":"26","author":"Agoff","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib17","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng1294-392","article-title":"Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families","volume":"8","author":"Simard","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib19","first-page":"1031","article-title":"BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2","volume":"60","author":"Schubert","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/gyno.2000.5740","article-title":"Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report","volume":"77","author":"Rose","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy as surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1025700807451","article-title":"Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study","volume":"2","author":"Piek","year":"2003","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib26","first-page":"89","article-title":"Papillary serous carcinoma of the peritoneum","volume":"75","author":"Fromm","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0046-8177(90)90081-F","article-title":"Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases","volume":"21","author":"Truong","year":"1990","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00004347-198203000-00003","article-title":"Serous surface papillary carcinoma of the ovary: a clinicopathologic study of 16 cases","volume":"1","author":"Gooneratne","year":"1982","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib29","first-page":"931","article-title":"Intra-abdominal carcinomatosis with histologically normal ovaries","volume":"68","author":"Hochster","year":"1984","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ygyno.2005.01.039_bib30","first-page":"403","article-title":"Serous surface papillary carcinoma: a clinical, pathologic, ultrastructural, and immunohistochemical study of 11 cases","volume":"20","author":"White","year":"1985","journal-title":"Pathol. Annu."},{"key":"10.1016\/j.ygyno.2005.01.039_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000478-198811000-00003","article-title":"Serous surface papillary carcinoma: a clinicopathologic study of 10 cases and comparison with stage III\u2013IV ovarian serous carcinoma","volume":"12","author":"Mills","year":"1988","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1999.5568","article-title":"Is uterine serous carcinoma a BRCA1-related disease? Case report and review of the literature","volume":"75","author":"Hornreich","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0029-7844(00)00851-6","article-title":"BRCA1 germline mutations in women with uterine serous papillary carcinoma","volume":"96","author":"Lavie","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib36","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2005.01.039_bib38","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1 mutation carriers","volume":"56","author":"Easton","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib39","first-page":"957","article-title":"Genetic heterogeneity of breast-ovarian cancer revisited","volume":"57","author":"Narod","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib40","first-page":"254","article-title":"An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families","volume":"56","author":"Narod","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12\u201313","volume":"61","author":"Easton","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0029-7844(98)00223-3","article-title":"BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum","volume":"92","author":"Bandera","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib44","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.01.039_bib45","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.01.039_bib46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study","volume":"95","author":"Rutter","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.01.039_bib47","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2005.01.039_bib48","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.01.039_bib49","first-page":"3776","article-title":"Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2","volume":"8","author":"Satagopan","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2005.01.039_bib50","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.01.039_bib51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2005.01.039_bib52","first-page":"93S","article-title":"Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome","volume":"66","author":"Chen","year":"1985","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib53","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.01.039_bib54","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation","volume":"91","author":"Stratton","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.01.039_bib55","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 and BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.22.2.255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2005.01.039_bib59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.2000.5861","article-title":"Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds","volume":"78","author":"Casey","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry","volume":"23","author":"Werness","year":"2004","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib61","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jnci\/90.13.995","article-title":"Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors","volume":"90","author":"Gotlieb","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.01.039_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0029-7844(98)00362-7","article-title":"A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer","volume":"93","author":"Lu","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib63","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib64","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib65","first-page":"733","article-title":"The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches","volume":"10","author":"Risch","year":"2001","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2005.01.039_bib66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00000478-199807000-00007","article-title":"Grade 1 peritoneal serous carcinoma: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors","volume":"22","author":"Weir","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib67","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/1097-0142(19920701)70:1<152::AID-CNCR2820700125>3.0.CO;2-6","article-title":"Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases","volume":"70","author":"deNictolis","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib69","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00000478-199611000-00004","article-title":"Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases","volume":"20","author":"Seidman","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib70","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1","article-title":"Ovarian serous borderline tumors with invasive peritoneal implants","volume":"82","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib71","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D","article-title":"Serous borderline tumors of the ovary with noninvasive peritoneal implants","volume":"83","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib72","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000478-199904000-00004","article-title":"Ovarian serous borderline tumors with micropapillary and cribiform patterns: a study of 40 cases and comparison with 44 cases without these patterns","volume":"23","author":"Eichorn","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-200104000-00001","article-title":"Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas","volume":"25","author":"Bell","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004347-200110000-00003","article-title":"Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma","volume":"20","author":"Lee","year":"2001","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib75","first-page":"663","article-title":"Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma","volume":"10","author":"Silva","year":"1997","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004347-200301000-00008","article-title":"Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases","volume":"22","author":"Gilks","year":"2003","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0029-7844(01)01675-1","article-title":"Epithelial ovarian tumors of low malignant potential: the role of microinvasion","volume":"99","author":"Buttin","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib79","first-page":"111","article-title":"Laparoscopic examination and assisted bilateral salpingo-oophorectomy hysterectomy for prophylactic removal of the ovaries and uterus in women at genetic risk for ovarian cancer","volume":"1","author":"Casey","year":"1995","journal-title":"J. Gynecol. Tech."},{"key":"10.1016\/j.ygyno.2005.01.039_bib80","first-page":"265","article-title":"Genetics and ovarian carcinoma","volume":"25","author":"Lynch","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/gyn.1994.10.7","article-title":"A critical analysis of laparoscopic assisted vaginal hysterectomies compared with vaginal hysterectomies unassisted by laparoscopy and transabdominal hysterectomies","volume":"10","author":"Casey","year":"1994","journal-title":"J. Gynecol. Surg."},{"key":"10.1016\/j.ygyno.2005.01.039_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1677\/erc.0.0100347","article-title":"Chemoprevention of breast cancer and trials of the National Surgical Adjuvant Breast and Bowel Project and others","volume":"10","author":"Smith","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminoncol.2003.08.002","article-title":"A review of selective estrogen receptor modulators and National Surgical Adjuvant Breast and Bowel Project clinical trials","volume":"30","author":"Smith","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib84","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ctrv.2003.09.004","article-title":"The effects of tamoxifen on the female genital tract","volume":"30","author":"Senkus-Konefka","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ygyno.2005.01.039_bib85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.AOG.0000131620.67911.03","article-title":"Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?","volume":"104","author":"Slomovitz","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib86","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib87","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0002-9378(96)70594-X","article-title":"Hormone replacement therapy in breast cancer survivors: a cohort study","volume":"174","author":"DiSaia","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib88","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1200\/JCO.1996.14.3.997","article-title":"Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?","volume":"14","author":"Roy","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.01.039_bib89","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.01.039_bib90","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/cncr.10913","article-title":"Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study","volume":"95","author":"Vassilopoulou-Sellin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.01.039_bib91","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1600-0412.2003.00551.x","article-title":"Hormone replacement therapy and risk of breast cancer: the role of progestins","volume":"82","author":"Stahlberg","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2005.01.039_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001703-200402000-00013","article-title":"Hormone replacement therapy and risk of malignancy","volume":"16","author":"Diamanti-Kandarakis","year":"2004","journal-title":"Curr. Opin. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T01:28:29Z","timestamp":1549416509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0090825805000958"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.01.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}